Evercore ISI Increases Doximity (NASDAQ:DOCS) Price Target to $29.00

Doximity (NASDAQ:DOCS - Get Free Report) had its price objective hoisted by equities research analysts at Evercore ISI from $28.00 to $29.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently has an "in-line" rating on the stock. Evercore ISI's price objective indicates a potential upside of 3.46% from the stock's current price.

Other research analysts also recently issued reports about the stock. Morgan Stanley reissued an "underweight" rating and set a $25.00 price target on shares of Doximity in a research note on Tuesday, April 23rd. JPMorgan Chase & Co. upgraded shares of Doximity from an "underweight" rating to a "neutral" rating and set a $25.00 target price on the stock in a research report on Thursday, April 25th. Bank of America upped their price target on shares of Doximity from $29.00 to $32.00 and gave the company a "neutral" rating in a research report on Tuesday, January 23rd. Needham & Company LLC reiterated a "hold" rating on shares of Doximity in a report on Friday. Finally, SVB Leerink began coverage on Doximity in a report on Monday, February 26th. They set a "market perform" rating and a $32.00 target price for the company. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $28.73.

Doximity Price Performance

DOCS stock traded up $4.29 during mid-day trading on Friday, hitting $28.03. 9,867,164 shares of the stock were exchanged, compared to its average volume of 1,799,228. The business has a fifty day moving average price of $25.65 and a 200 day moving average price of $26.43. Doximity has a 12 month low of $19.71 and a 12 month high of $36.29. The stock has a market capitalization of $5.23 billion, a price-to-earnings ratio of 42.47, a PEG ratio of 3.00 and a beta of 1.18.

Insider Buying and Selling at Doximity

In other news, Director Kira Scherer Wampler sold 2,500 shares of the stock in a transaction that occurred on Friday, May 17th. The stock was sold at an average price of $27.22, for a total value of $68,050.00. Following the completion of the transaction, the director now owns 10,258 shares of the company's stock, valued at approximately $279,222.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director Kira Scherer Wampler sold 2,500 shares of the business's stock in a transaction on Friday, May 17th. The shares were sold at an average price of $27.22, for a total transaction of $68,050.00. Following the sale, the director now owns 10,258 shares in the company, valued at approximately $279,222.76. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Craig Overpeck sold 1,500 shares of the stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $23.85, for a total transaction of $35,775.00. Following the completion of the transaction, the insider now owns 108,609 shares of the company's stock, valued at $2,590,324.65. The disclosure for this sale can be found here. In the last three months, insiders have sold 6,500 shares of company stock valued at $171,250. 39.40% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Doximity

Large investors have recently made changes to their positions in the business. iA Global Asset Management Inc. increased its holdings in shares of Doximity by 28.2% during the first quarter. iA Global Asset Management Inc. now owns 32,737 shares of the company's stock valued at $881,000 after acquiring an additional 7,208 shares in the last quarter. Comerica Bank increased its stake in Doximity by 4.1% during the 1st quarter. Comerica Bank now owns 63,704 shares of the company's stock valued at $1,714,000 after purchasing an additional 2,480 shares in the last quarter. Jacobs Levy Equity Management Inc. purchased a new position in Doximity in the first quarter worth about $8,541,000. Janus Henderson Group PLC lifted its stake in shares of Doximity by 33.5% in the first quarter. Janus Henderson Group PLC now owns 2,474,695 shares of the company's stock worth $66,594,000 after buying an additional 621,590 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD grew its holdings in shares of Doximity by 0.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 559,826 shares of the company's stock valued at $15,065,000 after buying an additional 2,190 shares during the last quarter. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.